Carl Decicco - Chief Scientific Officer, Foghorn Therapeutics Inc
As of February 1, 2021
Carl Decicco Net Worth
- Net worth is estimated to be at least $2.78M
- Owns at least 258,397 units of Foghorn Therapeutics Inc stock
Carl Decicco Compensation at Foghorn Therapeutics Inc in 2020
- Earned a $412.000 salary
- Received a total compensation of $1,218,464
Carl Decicco Trading
- Largest purchase of shares was 5,500 units , worth over $88K on October 29, 2020
- In total has made about 2 transactions over a year
- Usually trades in February and October, with the busiest year in 2021 and 2020
CARL DECICCO
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
Carl Decicco Mailing Address
- Mailing address is 100 Binney Street Suite 610 Cambridge MA 02142 MA
Foghorn Therapeutics Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Adrian Gottschalk | 2020 | $478,950 | - | $1,834,007 | $311,318 | - | $2,624,575 |
| Adrian Gottschalk | 2019 | $465,000 | - | $642,918 | $197,625 | - | $1,305,543 |
| Carl Decicco, Ph.D. | 2020 | $412.000 | - | $542,224 | $214,240 | $50,000 | $1,218,464 |
| Carl Decicco, Ph.D. | 2019 | $400,000 | - | $1,474,337 | $136,000 | $60,000 | $2,070,337 |
| Michael LaCascia | 2020 | $59,423 | $60,000 | $1,869,416 | - | - | $1,988,838 |
| Samuel Agresta, M.D. | 2020 | $412,000 | - | $542,224 | $99,573 | - | $1,053,797 |
| Samuel Agresta, M.D. | 2019 | $116,667 | $300,000 | $785,607 | - | - | $1,202,274 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1822462/000119312521178596/d105885ddef14a.htm
Foghorn Therapeutics Inc Insider Trading
- The most recent transaction was 5,500 units bought on October 29, 2020 by Carl Decicco worth over $88K
- In the years Foghorn Therapeutics Inc was active, insiders at Foghorn Therapeutics Inc bought an estimated value of $5M
- The most active traders are Adrian Gottschalk, Chief Executive Officer, Allan Reine, Chief Financial Officer, and Carl Decicco, Chief Scientific Officer
- Insider trading is most common in July, with the busiest year in 2021
Foghorn Therapeutics Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||